KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Capital Expenditures (2016 - 2025)

National Health Investors (NHI) has disclosed Capital Expenditures for 16 consecutive years, with $143.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures rose 11.56% year-over-year to $143.1 million, compared with a TTM value of $274.1 million through Dec 2025, up 98.42%, and an annual FY2025 reading of $274.1 million, up 98.42% over the prior year.
  • Capital Expenditures was $143.1 million for Q4 2025 at National Health Investors, up from $56.5 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $143.1 million in Q4 2025 and bottomed at -$4.9 million in Q4 2022.
  • Average Capital Expenditures over 5 years is $41.4 million, with a median of $23.2 million recorded in 2023.
  • The sharpest move saw Capital Expenditures tumbled 90.14% in 2023, then soared 1951.14% in 2024.
  • Year by year, Capital Expenditures stood at $46.8 million in 2021, then plummeted by 110.42% to -$4.9 million in 2022, then surged by 850.9% to $36.6 million in 2023, then skyrocketed by 250.31% to $128.3 million in 2024, then grew by 11.56% to $143.1 million in 2025.
  • Business Quant data shows Capital Expenditures for NHI at $143.1 million in Q4 2025, $56.5 million in Q2 2025, and $74.5 million in Q1 2025.